Additional file 4: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

October 2016

(See the editorial commentary by Lewis on pages 212–4) Background. Voriconazole is the therapy of ch...

Voriconazole salvage treatment of invasive candidiasis.

Ostrosky-Zeichner, L.
Oude Lashof, A.M.L.
Kullberg, B.J.
Rex, J.H.

January 2003

Item does not contain fulltextData on the salvage treatment of invasive candidiasis with voriconazol...

VORICONAZOLE-INDUCED HEPATOTOXICITY CONCISE UP-TO-DATE REVIEW

GÜMÜŞTEKİN, MUKADDES
Ertem, Ozge

January 2022

Voriconazole is a wide spectrum antifungal used primarily for invasive aspergillosis, an invasive mo...

Additional file 3: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Yuanming Xing (4722273)
Lu Chen (75170)
Yan Feng (128912)
Yan Zhou (6523)
Yajing Zhai (4329064)
Jun Lu (36049)

December 2017

A summary of sensitive analysis for voriconazole safety after excluding a group of studies which was...

Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Yuanming Xing
Lu Chen
Yan Feng
Yan Zhou
Yajing Zhai
Jun Lu

December 2017

Abstract Background Voriconazole has been used in the treatment and prophylaxis of invasive fungal i...

Additional file 1: of Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis

Lu Chen (75170)
Yan Wang (15435)
Tao Zhang (43681)
Ying Li (38224)
Ti Meng (5049200)
Leichao Liu (5049197)
Ruifang Hao (5049194)
Yalin Dong (3592028)

April 2018

Table S1. Summary of sensitive analysis for prophylaxis efficacy. Figure S1. Source of bias in two r...

Additional file 1: of Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis

Ken Chen (61463)
Qi Wang (22418)
Roy Pleasants (3760012)
Long Ge (511458)
Wei Liu (20030)
Kangning Peng (3760009)
Suodi Zhai (3328581)

February 2017

Table S1. Sample search strategy for MEDLINE. Table S2. The reason for excluding studies. Table S3. ...

Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat George R Thompson III

February 2011

Asma Lat1 George R Thompson III21Department of Pharmacy, New York-Presbyterian Hospital, Columbia Un...

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Donnelly, J.P.
Pauw, B.E. de

January 2004

Contains fulltext : 59076.pdf (publisher's version ) (Closed access)Voriconazole i...

Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Jin, Haiying
Wang, Tiansheng
Falcione, Bonnie A.
Olsen, Keith M.
Chen, Ken
Tang, Huilin
Hui, John
Zhai, Suodi

January 2016

Objectives: The optimum trough concentration of voriconazole for clinical response and safety is con...

Therapeutic drug monitoring of voriconazole.

Bruggemann, R.J.M.
Donnelly, J.P.
Aarnoutse, R.E.
Warris, A.
Blijlevens, N.M.A.
Mouton, J.W.
Verweij, P.E.
Burger, D.M.

January 2008

Contains fulltext : 70639.pdf (publisher's version ) (Closed access)Voriconazole i...

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

Kullberg, B.J.
Sobel, J.D.
Ruhnke, M.
Pappas, P.G.
Viscoli, C.
Rex, J.H.
Cleary, J.D.
Rubinstein, E.
Church, L.W.
Brown, J.M.
Schlamm, H.T.
Oborska, I.T.
Hilton, F.
Hodges, M.R.

January 2005

Contains fulltext : 48229.pdf (publisher's version ) (Closed access)BACKGROUND: Vo...

Additional file 1: of The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis

Libing Jiang (669302)
Yi Sheng (87897)
Xia Feng (179439)
Jing Wu (54032)

March 2019

Table S1. Study search strategy. Table S2. Information on excluded studies. Table S3. List of Ongoin...

Additional file 3: of Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Lefteris Floros (6323558)
Daniel Kuessner (5640473)
Jan Posthumus (5640476)
Emma Bagshaw (3347507)
Jan SjĂślin (6323564)

February 2019

Table S3. Parameters tested in deterministic sensitivity analysis. Table summarising the parameters ...

Pharmacodynamic Studies of Voriconazole: Informing the Clinical Management of Invasive Fungal Infections

Job, Kathleen M.
Olson, Jared K.
Stockmann, Chris
Constance, Jonathan E.
Enioutina, Elena Yu
Rower, Joseph E.
Linakis, Matthew W.
Balch, Alfred H.
Yu, Tian
Liu, Xiaoxi
Thorell, Emily A.
Sherwin, Catherine M.T.

September 2019

Introduction: Voriconazole is a broad-spectrum antifungal agent commonly used to treat invasive fung...

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

October 2016

(See the editorial commentary by Lewis on pages 212–4) Background. Voriconazole is the therapy of ch...

Voriconazole salvage treatment of invasive candidiasis.

Ostrosky-Zeichner, L.
Oude Lashof, A.M.L.
Kullberg, B.J.
Rex, J.H.

January 2003

Item does not contain fulltextData on the salvage treatment of invasive candidiasis with voriconazol...

VORICONAZOLE-INDUCED HEPATOTOXICITY CONCISE UP-TO-DATE REVIEW

GÜMÜŞTEKİN, MUKADDES
Ertem, Ozge

January 2022

Voriconazole is a wide spectrum antifungal used primarily for invasive aspergillosis, an invasive mo...

Additional file 3: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Yuanming Xing (4722273)
Lu Chen (75170)
Yan Feng (128912)
Yan Zhou (6523)
Yajing Zhai (4329064)
Jun Lu (36049)

December 2017

A summary of sensitive analysis for voriconazole safety after excluding a group of studies which was...

Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Yuanming Xing
Lu Chen
Yan Feng
Yan Zhou
Yajing Zhai
Jun Lu

December 2017

Abstract Background Voriconazole has been used in the treatment and prophylaxis of invasive fungal i...

Additional file 1: of Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis

Lu Chen (75170)
Yan Wang (15435)
Tao Zhang (43681)
Ying Li (38224)
Ti Meng (5049200)
Leichao Liu (5049197)
Ruifang Hao (5049194)
Yalin Dong (3592028)

April 2018

Table S1. Summary of sensitive analysis for prophylaxis efficacy. Figure S1. Source of bias in two r...

Additional file 1: of Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis

Ken Chen (61463)
Qi Wang (22418)
Roy Pleasants (3760012)
Long Ge (511458)
Wei Liu (20030)
Kangning Peng (3760009)
Suodi Zhai (3328581)

February 2017

Table S1. Sample search strategy for MEDLINE. Table S2. The reason for excluding studies. Table S3. ...

Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat George R Thompson III

February 2011

Asma Lat1 George R Thompson III21Department of Pharmacy, New York-Presbyterian Hospital, Columbia Un...

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Donnelly, J.P.
Pauw, B.E. de

January 2004

Contains fulltext : 59076.pdf (publisher's version ) (Closed access)Voriconazole i...

Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Jin, Haiying
Wang, Tiansheng
Falcione, Bonnie A.
Olsen, Keith M.
Chen, Ken
Tang, Huilin
Hui, John
Zhai, Suodi

January 2016

Objectives: The optimum trough concentration of voriconazole for clinical response and safety is con...

Therapeutic drug monitoring of voriconazole.

Bruggemann, R.J.M.
Donnelly, J.P.
Aarnoutse, R.E.
Warris, A.
Blijlevens, N.M.A.
Mouton, J.W.
Verweij, P.E.
Burger, D.M.

January 2008

Contains fulltext : 70639.pdf (publisher's version ) (Closed access)Voriconazole i...

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

Kullberg, B.J.
Sobel, J.D.
Ruhnke, M.
Pappas, P.G.
Viscoli, C.
Rex, J.H.
Cleary, J.D.
Rubinstein, E.
Church, L.W.
Brown, J.M.
Schlamm, H.T.
Oborska, I.T.
Hilton, F.
Hodges, M.R.

January 2005

Contains fulltext : 48229.pdf (publisher's version ) (Closed access)BACKGROUND: Vo...

Additional file 1: of The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis

Libing Jiang (669302)
Yi Sheng (87897)
Xia Feng (179439)
Jing Wu (54032)

March 2019

Table S1. Study search strategy. Table S2. Information on excluded studies. Table S3. List of Ongoin...

Additional file 3: of Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Lefteris Floros (6323558)
Daniel Kuessner (5640473)
Jan Posthumus (5640476)
Emma Bagshaw (3347507)
Jan SjĂślin (6323564)

February 2019

Table S3. Parameters tested in deterministic sensitivity analysis. Table summarising the parameters ...

Pharmacodynamic Studies of Voriconazole: Informing the Clinical Management of Invasive Fungal Infections

Job, Kathleen M.
Olson, Jared K.
Stockmann, Chris
Constance, Jonathan E.
Enioutina, Elena Yu
Rower, Joseph E.
Linakis, Matthew W.
Balch, Alfred H.
Yu, Tian
Liu, Xiaoxi
Thorell, Emily A.
Sherwin, Catherine M.T.

September 2019

Introduction: Voriconazole is a broad-spectrum antifungal agent commonly used to treat invasive fung...

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

October 2016

(See the editorial commentary by Lewis on pages 212–4) Background. Voriconazole is the therapy of ch...

Voriconazole salvage treatment of invasive candidiasis.

Ostrosky-Zeichner, L.
Oude Lashof, A.M.L.
Kullberg, B.J.
Rex, J.H.

January 2003

Item does not contain fulltextData on the salvage treatment of invasive candidiasis with voriconazol...

VORICONAZOLE-INDUCED HEPATOTOXICITY CONCISE UP-TO-DATE REVIEW

GÜMÜŞTEKİN, MUKADDES
Ertem, Ozge

January 2022

Voriconazole is a wide spectrum antifungal used primarily for invasive aspergillosis, an invasive mo...

Additional file 4: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Abstract

Extracted data

Additional file 4: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Abstract

Extracted data

Related items

Related items